Exelon (EXC) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates

07.02.25 15:15 Uhr

Werte in diesem Artikel
Aktien

40,00 EUR 0,47 EUR 1,18%

Indizes

PKT PKT

3.531,4 PKT 2,1 PKT 0,06%

21.491,3 PKT -282,8 PKT -1,30%

17.225,7 PKT -116,9 PKT -0,67%

2.936,1 PKT -34,7 PKT -1,17%

6.026,0 PKT -57,6 PKT -0,95%

In its upcoming report, Exelon (EXC) is predicted by Wall Street analysts to post quarterly earnings of $0.59 per share, reflecting a decline of 1.7% compared to the same period last year. Revenues are forecasted to be $5.45 billion, representing a year-over-year increase of 1.6%.Over the last 30 days, there has been an upward revision of 1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.Given this perspective, it's time to examine the average forecasts of specific Exelon metrics that are routinely monitored and predicted by Wall Street analysts.The combined assessment of analysts suggests that 'Operating revenues- ComEd' will likely reach $1.98 billion. The estimate indicates a year-over-year change of -1.5%.The collective assessment of analysts points to an estimated 'Operating revenues- PECO' of $974.99 million. The estimate suggests a change of +6.3% year over year.Analysts predict that the 'Operating revenues- BGE' will reach $1.06 billion. The estimate suggests a change of +1.4% year over year.Analysts forecast 'Operating revenues- PHI' to reach $1.49 billion. The estimate indicates a change of +5.7% from the prior-year quarter.According to the collective judgment of analysts, 'Natural gas revenues- BGE' should come in at $256.22 million. The estimate suggests a change of +0.5% year over year.The average prediction of analysts places 'Electric revenues- DPL' at $379.74 million. The estimate indicates a change of +5.5% from the prior-year quarter.Analysts expect 'Electric revenues- ACE' to come in at $390.69 million. The estimate points to a change of +11.6% from the year-ago quarter.The consensus estimate for 'Electric revenues- PHI' stands at $1.47 billion. The estimate indicates a change of +8.7% from the prior-year quarter.Based on the collective assessment of analysts, 'Natural gas revenues- PHI' should arrive at $52.22 million. The estimate points to a change of -5.1% from the year-ago quarter.Analysts' assessment points toward 'Natural gas revenues- PECO' reaching $175.17 million. The estimate suggests a change of -12% year over year.It is projected by analysts that the 'Electric revenues- BGE' will reach $794.76 million. The estimate points to a change of +1.1% from the year-ago quarter.The consensus among analysts is that 'Electric revenues- PECO' will reach $802.17 million. The estimate points to a change of +11.7% from the year-ago quarter.View all Key Company Metrics for Exelon here>>>Shares of Exelon have experienced a change of +7.7% in the past month compared to the +1.9% move of the Zacks S&P 500 composite. With a Zacks Rank #2 (Buy), EXC is expected to outperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Free Today: Profiting from The Future’s Brightest Energy SourceThe demand for electricity is growing exponentially. At the same time, we’re working to reduce our dependence on fossil fuels like oil and natural gas. Nuclear energy is an ideal replacement.Leaders from the US and 21 other countries recently committed to TRIPLING the world’s nuclear energy capacities. This aggressive transition could mean tremendous profits for nuclear-related stocks – and investors who get in on the action early enough.Our urgent report, Atomic Opportunity: Nuclear Energy's Comeback, explores the key players and technologies driving this opportunity, including 3 standout stocks poised to benefit the most.Download Atomic Opportunity: Nuclear Energy's Comeback free today.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Exelon Corporation (EXC): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Exelon

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Exelon

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Exelon Corp.

Wer­bung

Analysen zu Exelon Corp.

DatumRatingAnalyst
13.08.2019Exelon OverweightBarclays Capital
24.07.2018Exelon Sector OutperformScotia Howard Weil
23.01.2018Exelon NeutralMizuho
15.05.2017Exelon BuyUBS AG
13.10.2016Exelon NeutralUBS AG
DatumRatingAnalyst
13.08.2019Exelon OverweightBarclays Capital
24.07.2018Exelon Sector OutperformScotia Howard Weil
15.05.2017Exelon BuyUBS AG
24.03.2016Exelon OverweightBarclays Capital
07.03.2016Exelon BuyArgus Research Company
DatumRatingAnalyst
23.01.2018Exelon NeutralMizuho
13.10.2016Exelon NeutralUBS AG
13.01.2016Exelon NeutralUBS AG
17.11.2015Exelon Sector PerformScotia Howard Weil
26.08.2015Exelon NeutralUBS AG
DatumRatingAnalyst
02.11.2012Exelon sellUBS AG
12.09.2012Exelon sellUBS AG

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Exelon Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"